Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
could be an insider buy. idk what else...
Volume Alert on IARO
EVRN 1 Week Performance + 3.08%
finally bottomed out?
lol i think this is "just" a rebound driven by biomedreports. but its cool, i like what they do :).
http://biomedreports.com/articles/most-popular/23523-observations-about-generex-gnbt-keryx-kerx-sunesis-snss-and-cel-sci-cvm.html
the stock has set up very nice but isnt at full strength yet. the chance is here...
hmm what kinda buying is going on here? looks very suspicious.
micmacpole, of course yes not the way CIT made their shareholders!
i just ment because of the comeback!
gl
strage, the symbol must have been already changed.
anyway im looking at CBAI now.
i guess no cant even find the symbol..???? it just was there and now no more.
btw, im swiss too. :)
yes, of course, its still and it will always be. :)
ahh mesa will come back like cit group. thumbs up.
too bad this was a great stock.
looks like they were right :).
Long, Longer, SRSR? i still have some shares i bought in the 0.08 range. will have to add some more since the price is good. lets see where we end with this.
does this has a chance to go up to the 50, 200 day MA??? :)
MiddleBrook Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace Rule 4350
WESTLAKE, Texas--(BUSINESS WIRE)--MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) announced today that on Dec. 31, 2009, it granted options to purchase a total of 5,000 shares of MiddleBrook's common stock to two (2) new employees as a material inducement for them to join MiddleBrook. The options were granted pursuant to NASDAQ Marketplace Rule 4350(i)(1)(A)(iv) and under MiddleBrook's New Hire Stock Incentive Plan, which was approved by MiddleBrook's Board of Directors on Sept. 26, 2008 and further ratified by the Company’s Compensation Committee on August 20, 2009. The options have a per share exercise price equal to the closing price of MiddleBrook's common stock on the NASDAQ Global Market on the business day immediately preceding the grant date, a ten-year term and vesting over four years, with 25 percent of the options vesting one year from the grant date and 1/48th of the options vesting monthly thereafter. The options have a grant date of Dec. 31, 2009.
yes, many times i thouht no its going down but just to get back up :)
and soon is dividend time, do you know the exact date?
regards
i had 3000 shares bought at 0.50 :(
jup very nice :). still needs to climb to 0.80 where i bought in :) but its runnin good, no comparison.
ALERT BreakOUT!!!
HOD at HYTM 0.59 (+13.46%) :)
good looks id like to see that aswell :). pre market high 0.60.
today aswell. ...
yup thinking the same. this could start to skyrock.
After hours again 0.550 +0.027 (5.16%) on 125,150 shares.
the RSI of the stock just moved over 70. somethings up here...
Anesiva Announces Merger With Arcion Therapeutics Will Not be Completed
SOUTH SAN FRANCISCO, Dec. 31 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that it was unable to satisfy the closing conditions set forth in the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation, a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto (the "Merger Agreement"). The Company intends to immediately cease operations and to file a petition for relief under the Bankruptcy Code.
About Anesiva
Anesiva seeks to be a leader in the development and commercialization of novel pharmaceutical products for pain management. Anesiva's lead product candidate is Adlea, a novel small molecule formulation of capsaicin that is currently in development for the management of acute pain following orthopedic surgeries. Adlea has been shown in clinical trials to provide extended pain relief after only a single administration in multiple indications for site-specific, acute and chronic, moderate-to-severe pain.
-50%
Hythiam After Hours: 0.485 +0.046 (10.48%) on 200 Shares. MM play?
hmm why did you bought in exactly now? i got at when it was over 5.... ive bought the shares for 3 bucks. in Nov
i hope your still sitting on your shares current price is at 0.93 :)
XD rofl. the only thing can help EWRC is a nice news flow with price action. yeah financials would be great and such stuff. we will see what will happen, dont stop believin. ;)
Happy New Year! :)
and might Hythiam have a better 2010 than 2009 was. All hope is in the Ford Contract and who knows we might sign a second one with a major company. I updated aswell some info into the iBox. Its nothign new, nothig special but since i was accepted as Mod here ill try to contribute. :)
best regards and a great 2010!
stockfreak
thank you :).
anyone know how many Authorized Shares are in here?
great news. i like this stock but time for artfest hasnt come yet. gl
lol, no hate aganst chartists :P. haha
lol how much lower can i buy this? ;)
sndy makes nice moves and has a good newsflow, the chart looks like its setting up. im watching this since a week two or so. gonna be time to get in i guess.
this is ewrc not asfx. two totaly different companies IMO.
the 15min chart shows a sell off...???
i had no time to buy i was busy watching it going higher and higher.. i almost puttet the trigger at 2.20 but than it started the move and things went fast.
lol, ahhhhh
this might end up in the 3.45 range. back to where it came from...